What does 'specificity' mean in immunoassays for drug screening?

What does 'specificity' mean in immunoassays for drug screening?

• A. The assay's ability to measure all drugs present.
• B. The assay's ability to measure only the targeted drug or metabolite with minimal cross-reactivity to non-target substances.
• C. The assay's speed.
• D. The assay's cost.

Answer: (B)

Specificity in immunoassays refers to the test’s ability to detect only the intended drug or its metabolite and to ignore other, non-target substances. In drug screening, antibodies are chosen or designed to bind a particular chemical structure. If those antibodies also bind substances that look similar, the test may indicate a positive result when the target drug isn’t actually present—the issue of cross-reactivity. A highly specific assay minimizes this cross-reactivity, giving accurate results by focusing on the targeted compound. This is why the option describing measuring only the targeted drug or metabolite with minimal cross-reactivity best matches what specificity means. Speed or cost aren’t measures of specificity, and aiming to detect all drugs would imply broad reactivity, not high specificity.

Specificity in immunoassays refers to the test’s ability to detect only the intended drug or its metabolite and to ignore other, non-target substances. In drug screening, antibodies are chosen or designed to bind a particular chemical structure. If those antibodies also bind substances that look similar, the test may indicate a positive result when the target drug isn’t actually present—the issue of cross-reactivity. A highly specific assay minimizes this cross-reactivity, giving accurate results by focusing on the targeted compound. This is why the option describing measuring only the targeted drug or metabolite with minimal cross-reactivity best matches what specificity means. Speed or cost aren’t measures of specificity, and aiming to detect all drugs would imply broad reactivity, not high specificity.